Zimmer Biomet Holdings Inc (ZBH)
101.54
-1.59
(-1.54%)
USD |
NYSE |
Jan 08, 16:00
102.00
+0.46
(+0.45%)
Pre-Market: 04:58
Zimmer Biomet Holdings SG&A Expense (Quarterly): 709.70M for Sept. 30, 2024
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
ResMed Inc | 238.98M |
Stryker Corp | 1.896B |
Eli Lilly and Co | 2.100B |
Merck & Co Inc | 2.731B |
Bio-Techne Corp | 119.16M |